MSI-H Colorectal Cancer

Who we are

  • January 9, 2024
    Efficacy and Safety of Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI Metastatic Colorectal Cancer ( NIPISAFE )
  • January 9, 2024
    NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
  • January 9, 2024
    Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer
  • April 5, 2022
    Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer